tm logo
VIJOICE
CANCELLED BY OWNER

on 05 Jun 2024

Last Applicant/ Owned by

NOVARTIS AG

CH-4002 Basel

CH

Serial Number

2101570 filed on 02th Mar 2021

Registration Number

TMA1166057 registered on 15th Feb 2023

Registration expiry Date

10th Mar 2030

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

VIJOICE

Vienna Information


26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 6

Surfaces or backgrounds covered with circles or ellipsesSurfaces ou fonds couverts de cercles ou d'ellipses

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 14

Dotted lines or bandsLignes ou bandes pointillées

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 3

GreenVert

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; antiinflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, antibacterials, antivirals, antibiotics, systemic and topical antifungals.


Classification kind code

11

Mark Details


Serial Number

2101570

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 23rd Aug 2022
Agent Changed
Submitted for opposition 22
on 17th Aug 2022
Search Recorded
Submitted for opposition 20
on 17th Aug 2022
Examiner's First Report
Submitted for opposition 223
on 17th Aug 2022
Total Provisional Refusal
Submitted for opposition 256
on 22nd Feb 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 22nd Apr 2021
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 21st Apr 2021
Created
Submitted for opposition 31
on 21st Apr 2021
Formalized
Submitted for opposition 30
on 02th Mar 2021
Filed
Submitted for opposition 228
on 10th Mar 2020
International Registration